CI Private Wealth »

Ultragenyx Pharmaceutical shares owned by CI Private Wealth

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 137k 20.95

More positions owned by CI Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Johnson & Johnson (JNJ)

View all positions for CI Private Wealth

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Sands Capital Management
Rtw Investments
FMR
Wellington Management Company
Citadel Advisors
Assenagon Asset Management
Two Sigma Investments
Frontier Capital Management

View all funds holding Ultragenyx Pharmaceutical